EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.13.11.52 | 1-Methyltryptophan | competitive | Mus musculus | |
1.13.11.52 | additional information | inhibition of indoleamine 2,3-dioxygenase may be developed as an anticancer immunotherapeutic strategy | Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.11.52 | L-Trp + O2 | Mus musculus | enzyme contributes to tumor cell evasion of T cell-mediated rejection | L-formylkynurenine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.13.11.52 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.13.11.52 | Lewis lung carcinoma cell line | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.11.52 | L-Trp + O2 | - |
Mus musculus | L-formylkynurenine | - |
? | |
1.13.11.52 | L-Trp + O2 | enzyme contributes to tumor cell evasion of T cell-mediated rejection | Mus musculus | L-formylkynurenine | - |
? |